Ignite Creation Date:
2024-05-05 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00315731
Status:
COMPLETED
Last Update Posted:
2017-07-11
First Post:
2006-04-17
Brief Title:
A Study Of Pharmacokinetics Whole Body And Organ Dosimetry And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab BEXXAR For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkins Lymphoma
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Organization Data
Organization:
GlaxoSmithKline
Class:
INDUSTRY
Study ID:
393229027
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GlaxoSmithKline
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None